Home › Funds › Weiss Asset Management LP › MLTX

Weiss Asset Management LP position in MLTX

MOONLAKE IMMUNOTHERAPEUTICS · Health Care

Weiss Asset Management LP reported holding 2,581,813 shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS) in its Q2 2026 13F filing — a position valued at US$50.3M, representing 0.91% of its reported portfolio and ranking #22 among its reported holdings. Weiss Asset Management LP has disclosed MLTX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)2.58M sh
Reported value held$50.27M
Portfolio Weight0.91%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Weiss Asset Management LP's MLTX position evolved

Weiss Asset Management LP first disclosed a stake in MLTX in Q4 2025 at 332,961 shares (US$4.4M). The position peaked in Q2 2026 at 2,581,813 shares, worth US$50.3M. Across 3 filings, Weiss Asset Management LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,581,813 shares valued at US$50.3M — an increase of 873,485 shares quarter over quarter.. Notable position changes include a 413% increase in Q1 2026 (shares rose 4% over the following quarter), a 51% increase in Q2 2026 (shares fell 40% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 332.96K $4.39M New
Q1 2026 1.71M $31.84M Add
Q2 2026 2.58M $50.27M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLTX and 13F data

MLTX (MOONLAKE IMMUNOTHERAPEUTICS) is a Health Care company. 29 other funds we track also report a position in MLTX — the largest reported positions include BVF INC/IL (US$311.5M), Deep Track Capital, LP (US$136.3M), Cormorant Asset Management, LP (US$62.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLTX

All MLTX fund holders →

FAQ

How long has Weiss Asset Management LP held MLTX?

Weiss Asset Management LP has disclosed MLTX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Weiss Asset Management LP's current position in MLTX?

As of Q2 2026, Weiss Asset Management LP holds 2.58M shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS), valued at $50.27M, representing 0.91% of its reported portfolio and ranking #22.

Has Weiss Asset Management LP been buying or selling MLTX?

In the latest 13F filing (Q2 2026), Weiss Asset Management LP increased its position in MLTX. The position peaked in Q2 2026 at 2.58M shares.

Which other funds hold MLTX?

Other major institutional holders of MLTX include BVF INC/IL, Deep Track Capital, LP, Cormorant Asset Management, LP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.